N eutrophils are the first leukocytes recruited to sites of infection or tissue damage, where they act by killing invading bacteria and promoting wound repair [1] [2] [3] . These properties of neutrophils have been recognized for several decades, the prevailing view being that they perform these functions following recruitment into inflamed tissue before dying in situ. The recent discovery that neutrophils in inflamed tissues exhibit a greatly extended lifespan of up to 5 days 4 suggests that these cells may participate in more complex activities such as shaping of innate and adaptive immune responses. Moreover, observations in humans 5 , mice 6 and zebrafish 7 suggest that neutrophils can re-enter the vasculature from inflamed tissues via reverse transmigration. The possibility that neutrophils may also emigrate from inflamed tissues via the lymphatics has also been supported by several studies analysing neutrophil localization in the lymph nodes in mice [8] [9] [10] as well as by analysis of afferent lymph in sheep [11] [12] [13] .
The potential for neutrophils to both survive for an extended period of time and migrate from sites of primary inflammation has led to a re-assessment of the role of these cells beyond direct pathogen destruction and wound repair. Neutrophils produce an array of molecules that recruit and activate other innate cells including monocytes, macrophages and dendritic cells 2 . In addition, a possible contribution by neutrophils in modulating adaptive immune responses has been supported by studies demonstrating that they can influence CD8 þ T-cell responses by cross-presenting exogenous antigens in vivo 14 . Other studies suggest that neutrophils may present antigen to CD4 þ T cells either directly 15, 16 or by fusing with DCs to form a hybrid cell population 17, 18 . However, the net effect of neutrophils on T-cell responses is likely to be contributed to by multiple neutrophil functions including removal and sequestration of antigen 10 , modulation of APC maturation and function 10 , inhibition of T-cell migration 19 as well as direct antigen presentation 15, 16 . Several recent studies have also highlighted a possible role for neutrophils in regulating B-cell responses 20, 21 .
Despite accumulating evidence that neutrophils can migrate out of primary inflammatory sites and potentially modify innate and adaptive immune responses, many questions remain unanswered. The differences in neutrophil behaviour in response to sterile and microbial inflammation remain to be characterized. In addition, the molecular basis for neutrophil migration from the site of primary injury to local lymph nodes has not been elucidated.
Here we describe a novel, photoconversion-based system designed to label cells that have migrated into inflamed skin and track them as they egress from a site of primary inflammation. While neutrophils entered inflamed skin in response to both bacterial and sterile injuries, migration to draining lymph nodes was dependent on the presence of bacteria. Neutrophils were the predominant leukocyte to leave microbial lesions and migrate via the lymphatic vessels to the draining lymph node in a process dependent on CD11b and CXCR4 but not CCR7. Although neutrophil persistence in the lymph nodes was reduced in comparison to inflamed skin, we found that skinegressing neutrophils were able to augment lymphocyte proliferation in draining lymph nodes. These data indicate a previously unappreciated level of communication between pathogens and neutrophils that promotes lymphatic migration of neutrophils and modulates downstream immune responses.
Results
Neutrophil recruitment to microbial and sterile lesions. To compare phenotypes and behaviour of neutrophils during the early stages of anti-bacterial and sterile immune responses, fluorescently conjugated and killed S. aureus was introduced intradermally into the mouse ear. A second cohort of mice received a sterile injury to the ear skin via a needle scratch while control mice remained unmanipulated. After 8 h, both sterile and bacterial injuries induced the recruitment of neutrophils (defined as Ly6G and CD11b positive) into the inflamed skin ( Fig. 1a top panel and Supplementary Fig. 1 ). However, accumulation of neutrophils in dorsal cervical lymph nodes that drain the ear was only observed when S. aureus bacteria were present in the primary lesion (Fig. 1a bottom panel and Supplementary Fig. 1 ). Flow cytometric analysis of neutrophils recruited to the skin in response to microbial or sterile injuries revealed differential expression of molecules associated with neutrophil migration and activation. Specifically, CD11b was preferentially expressed on neutrophils recruited in response to S. aureus, while CD62L and CXCR2 were higher on neutrophils responding to sterile injury ( Fig. 1b) . Thus, despite similar levels of neutrophil recruitment to sites of bacterial and sterile inflammation, neutrophils show phenotypic and migration differences very early in the response.
Neutrophils emigrate from microbial but not sterile lesions.
To determine whether the neutrophils initially recruited to the primary skin wound underwent subsequent migration to other organs or remained in the skin, we utilized transgenic mice that ubiquitously express the coral-derived fluorescent protein Kikume. Kikume has a native green fluorescence but can be irreversibly converted to red fluorescence by exposure to ultraviolet or violet light 22 . The experimental approach used is summarized in Fig. 1c . First, Kikume transgenic mice were challenged by ear injection of S. aureus or a sterile needle scratch. After 4 h (a time point chosen to allow for neutrophil recruitment into skin), inflamed ears were photoconverted by exposure to white light as previously described 23 . A further 4 h later, mice were killed and photoconverted cells were detected in blood, draining lymph nodes and other immune organs using flow cytometry. In mice challenged with S. aureus, substantial numbers of photoconverted neutrophils were found in draining but not in non-draining lymph nodes ( Fig. 1d top panel and Supplementary Fig. 2a ). Photoconverted neutrophils could also be detected in peripheral blood of these mice but at 10-fold lower frequencies compared with draining lymph nodes ( Fig. 1d and Supplementary Fig. 2b ). In contrast, mice receiving a sterile scratch to the ear showed few photoconverted neutrophils in the draining lymph nodes despite the presence of these cells in the blood (Fig. 1d middle panel and Supplementary Fig. 2b ). Flow cytometric analysis revealed that neutrophils comprised B80% of the photoconverted cells found in the draining lymph nodes of S. aureus-injected mice as well as the majority of the photoconverted cells in all other organs ( Fig. 1e ).
Although neutrophils recruited in response to S. aureus persisted in the ear for several days, the number of photoconverted neutrophils in draining lymph nodes rapidly declined and returned to basal levels B36 h after infection ( Fig. 1f ). By 48 h after challenge, dendritic cells were the predominant skin-emigrant population in draining lymph nodes ( Fig. 1g ). This decline in neutrophil numbers is likely due to both a decrease in migration as well as rapid death of lymph node neutrophils as suggested by substantially higher staining for the apoptotic marker Annexin V in draining lymph node neutrophils compared with those in skin ( Fig. 1h ). Annexin V binding was increased in both S. aureus-containing and non-containing draining lymph node neutrophils ( Fig. 1h ). Thus, neutrophils were the major immune subset to emigrate from inflamed skin at the very early stages of the immune response and their migration to draining lymph nodes was dependent on the presence of bacteria.
Neutrophils migrate from skin to lymph nodes via lymphatics.
From the data presented in Fig. 1d , it was clear that migration of skin-egressing neutrophils to draining lymph nodes required the presence of S. aureus whereas reverse transmigration into blood vessels did not. We, therefore, postulated that the afferent lymphatic vessels rather than blood were the major route of neutrophil egress from the bacterial skin lesion to the draining lymph node. To distinguish between blood versus lymphatic migration of neutrophils from the skin wound to draining lymph nodes, we first examined the localization of photoconverted cells S. aureus (Sa) þ neutrophils (blue), S. aureus À neutrophils (red). Data were analysed using an unpaired student's t-test (b), one-way analysis of variance (ANOVA) with a Bonferroni correction for multiple comparisons (f) or a two-way ANOVA with a Bonferroni correction (g,h). *Pr0.05; **Pr0.01; ***Pr0.001; ****Pr0.0001; NS, not significant. NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8139 ARTICLE within the draining nodes of Kikume transgenic mice. Twophoton imaging after S. aureus injection and ear photoconversion showed that 4-6 h after infection, the majority of photoconverted cells were located in the subcapsular sinus of draining lymph nodes, with some of the cells also spreading deeper into the node (Fig. 2a ). Localization of photoconverted cells in or near the subcapsular sinus strongly suggests that they entered the node via the lymphatics rather than the blood. Furthermore, when we examined neutrophil interactions with the lymphatic vessels in infected ears of Lysozyme M fluorescent reporter mice that allow visualization of neutrophils 9 , we detected neutrophils inside LYVE-1 þ lymphatic vessels in inflamed ears (Fig. 2b ). In addition, the first in vivo visualization of neutrophil migration inside the lymphatics was obtained ( Fig. 2c and Supplementary Video 1).
We confirmed our observations of neutrophil migration in lymphatic vessels by transferring bone marrow from Lysozyme M fluorescent mice into Albino.BL/6 recipients (which are less susceptible to photodamage during imaging than black mice 24 ) to obtain a fluorescently labelled population of ear neutrophils of 495% purity ( Supplementary Fig. 3 ). Using this method, we found that neutrophils crawled inside the lymphatic vessels with a mean speed of 13 mm min À 1 (Fig. 2d ), frequently reversing direction of migration (Supplementary Videos 1 and 2). Although intralymphatic neutrophils were relatively infrequent (o1% of total neutrophils were found inside the lymphatics since the majority of neutrophils were clustered around foci of S. aureus infection), we also detected multiple neutrophils migrating in the same lymphatic vessel (Supplementary Video 2). Furthermore, neutrophils in lymphatic vessels were observed to carry fluorescently labelled S. aureus ( Fig. 2e and Supplementary Video 2). Consistent with this, flow cytometric analysis demonstrated that neutrophils were the main cell type containing fluorescent bacteria in the ear as well as in draining lymph nodes. In contrast, few bacteria-containing cells could be detected in circulation and other organs ( Fig. 2f and Supplementary Fig. 4 ). Together, these data indicated that S. aureus-carrying neutrophils were primarily directed to the draining lymph node via lymphatic vessels and only rarely underwent reverse transmigration to egress via blood vessels.
Neutrophil migration to lymph nodes is independent of CCR7. Molecular events involved in neutrophil recruitment from the bloodstream to the site of inflammation have been well defined. However, the mechanisms responsible for neutrophil egress from inflamed tissue and their migration to draining lymph nodes are poorly understood. Since chemokine receptor CCR7 has been implicated in neutrophil entry into lymph nodes 25 , we examined inflamed lymph nodes in Ccr7 À / À mice. Unexpectedly, we did not observe any decrease in neutrophils in both draining and non-draining lymph nodes of Ccr7 À / À mice ( Fig. 3a) suggesting that CCR7-deficient neutrophils readily entered lymph nodes. To determine whether CCR7-deficient neutrophils are at a competitive disadvantage with respect to lymph node homing, we intravenously co-transferred bone marrow from Ccr7 À / À mice (CD45.2 congenic variant) and wild-type Tomato transgenic mice (CD45.2 ROSA mT/mG expressing Tomato fluorescent protein) into CD45.1 congenic recipients. The mice were then challenged with S. aureus. Flow cytometric analysis performed 6-8 h later failed to reveal any difference in wild-type and CCR7-deficient neutrophil recruitment to lymph nodes and other organs after challenge (Fig. 3b ). Thus CCR7 expression was not required for neutrophil entry into lymph nodes. Finally, we wanted to query specifically whether neutrophil migration from skin to lymph nodes is affected in the absence of CCR7. To take advantage of the photoconvertible system, CCR7deficient mice were crossed to Kaede transgenic mice 26 , which can be photoconverted from green to red using the same method as Kikume mice. These mice were challenged by ear injection of S. aureus and photoconverted as previously. A further 4 h later, mice were killed and photoconverted cells were detected in blood, draining lymph nodes and other immune organs using flow cytometry. CCR7-deficient and CCR7-heterozygous littermate control neutrophils migrated from skin to draining lymph nodes with similar efficiency (Fig. 3c ). Thus CCR7 deficiency did not impair neutrophil migration from inflamed skin to draining lymph nodes.
CD11b and CXCR4 modulate neutrophil migration from skin. To identify alternative candidate molecules that may play a role in neutrophil migration to draining lymph nodes, we examined the phenotype of neutrophils in different organs after S. aureus challenge (Fig. 4a ). We noted that draining lymph node neutrophils expressed elevated levels of the chemokine receptor CXCR4 as well as the integrin and complement receptor CD11b, while neutrophils in inflamed ears expressed lower levels of CD62L, CXCR2 and CXCR4 compared with other tissues (Fig. 4a ).
We next examined the phenotype of lymph node neutrophils following S. aureus challenge and ear photoconversion. Photoconverted neutrophils that had recently entered the lymph node from inflamed skin could be distinguished on the basis of altered expression of CD11b, CD62L and CXCR2, while CXCR4 was expressed at similar levels in photoconverted and total neutrophils (Fig. 4b ,c).
We tested the role of these molecules in migration from skin to draining lymph nodes. To differentiate between mechanisms of recruitment to inflamed tissue and subsequent egress from skin to ARTICLE lymph nodes, we first injected S. aureus into the ears of Kikume transgenic photoconvertible mice, allowed neutrophils to be recruited into the inflamed ear for 4 h and then administered blocking antibodies (anti-CD11b, -CD62L) or inhibitors of CXCR2 or CXCR4 intradermally into the ear. Inflamed ears were photoconverted immediately after and lymph nodes were analysed for the presence of photoconverted neutrophils after a further 4 h. Topical administration of anti-CD11b antibody to ears did not alter neutrophil uptake of S. aureus bioparticles (data not shown) but led to a 5-fold reduction in the numbers of Kikume red (recently-arrived) neutrophils in the draining lymph nodes (Fig. 4d ) indicating that CD11b may play a role in neutrophil migration from skin to draining lymph nodes.
In contrast to anti-CD11b, localized administration of anti-CD62L failed to inhibit neutrophil migration from skin to draining lymph nodes, despite blocking recruitment from blood to inflamed ears when administered intravenously (Supplementary Table 1 and Supplementary Fig. 5 ). This indicates that the effect of anti-CD11b blockade on neutrophil migration is not due to IgG-mediated complement activation nor to generic effects of antibody binding on cell migration.
We confirmed a key role for CD11b in modulating neutrophil migration from skin to lymph nodes by transferring labelled bone marrow neutrophils from CD11b-deficient and wild-type mice directly into the ears of recipient mice that received S. aureus 4 h earlier. Flow cytometric analysis of ear and lymph node suspensions after a further 4 h showed a significant decrease in the ratio of CD11b-deficient neutrophils (relative to the cotransferred wild-type cells) in draining lymph nodes compared with ears ( Supplementary Fig. 6 ), thus confirming that CD11b plays a role in neutrophil migration from inflamed skin to draining lymph nodes.
Localized CXCR2 blockade did not alter the migration of neutrophils from skin to the lymph nodes. However, administration of the CXCR4 inhibitor plerixafor/AMD3100 led to a significant reduction in the proportion of photoconverted neutrophils in draining lymph nodes. Notably, administration of pertussis toxin did not inhibit neutrophil migration from ears to draining lymph nodes ( Supplementary Table 1 ) suggesting that CXCR4 may be modulating neutrophil migration from skin in a Gai-independent manner.
We also used our photoconversion model to test several other molecules that may play a role in neutrophil migration via blocking antibodies or isotype controls or CXCR2 or CXCR4 inhibitors or vehicle controls were administered to the ears 4 h after S. aureus injection, ears were photoconverted immediately afterwards and percentages of photoconverted neutrophils out of all lymph node cells were determined 4 h later. Data were pooled from at least two independent experiments. Data were analysed using a one-way analysis of variance with a Bonferroni correction for multiple comparisons (a) or a paired student's t-test (c) or an unpaired student's t-test (d) *Pr0.05; **Pr0.01; ***Pr0.001; ****Pr0.0001; NS, not significant. lymphatic vessels including ICAM-1 and LYVE-1 (expressed by lymphatic endothelial cells) and the integrin CD11a (involved in neutrophil migration to the site of inflammation, Supplementary  Table 1 ). Targeting of these molecules had no effect on neutrophil migration from skin to draining lymph nodes, even though intravenous administration of ICAM-1 and CD11a prevented neutrophil recruitment to inflamed tissue (Supplementary Table 1 ) as was expected from published studies 3 . Thus, we have uncovered roles for both CD11b and CXCR4 in mediating neutrophil migration via lymphatic vessels from skin to draining lymph nodes.
Neutrophils regulate early adaptive immune responses. We next asked how neutrophils affect adaptive immune responses in draining lymph nodes. Neutrophils were depleted by two intraperitoneal injections of a neutrophil-specific anti-Ly6G antibody (50 mg 1 day prior as well as at the time of bacterial challenge) and lymphocyte proliferation was analysed by BrdU incorporation 3 days after S. aureus injection. Compared with animals that received control antibody, significantly fewer BrdU þ T and B cells were observed in neutrophil-depleted mice (Fig. 5a,b ). This was true for both CD4 þ and CD8 þ T cells although the effect on CD8 T-cell proliferation was more pronounced (Fig. 5c ). Thus neutrophils appeared to enhance early adaptive immune responses in draining lymph nodes.
This effect correlated with higher levels of MHC class II ( Supplementary Fig. 7a ) as well as the co-stimulatory molecules, CD80 and CD86 ( Supplementary Fig. 7b ) on draining lymph node neutrophils compared with neutrophils in other organs (with the exception of bone marrow). Furthermore, MHC class II expression on S. aureus-containing neutrophils was increased compared with neutrophils, which lacked bacteria and comparable to levels on Ly6G À CD11b þ cells (macrophages and dendritic cells, Supplementary Fig. 7c ) suggesting a link between MHC class II expression and neutrophil phagocytosis and activation.
Finally, we set out to show that specific inhibition of CD11bmediated neutrophil migration from skin to draining lymph nodes could modulate early adaptive immune responses. To demonstrate this, we transferred S. aureus-pulsed CD11bdeficient or wild-type neutrophils directly into the ear pinna of mice previously depleted of neutrophils via a single injection of 50 mg of anti-Ly6G antibody. T-cell proliferation was assessed by BrdU incorporation 72 h later. We found that proliferation of both CD4 þ and CD8 þ T cells was significantly lower in response to CD11b-deficient neutrophils compared with wildtype neutrophils (Fig. 6 ). To ensure that this is not due to a functional defect in CD11b-deficient neutrophils, we also transferred wild-type S. aureus-pulsed neutrophils that had been pre-incubated with either a CD11b-blocking antibody or an isotype control. Both CD4 þ and CD8 þ T-cell proliferation was significantly reduced in mice that received neutrophils treated with anti-CD11b compared with control animals ( Supplementary  Fig. 8 ). Thus, we provide evidence that CD11b-dependent neutrophil migration from skin affects adaptive immune responses in draining lymph nodes. Since blocking CXCR4 also reduced neutrophil migration from skin to draining lymph nodes, we expect that inhibition of CXCR4 would lead to a similar decrease in T-cell proliferation in draining lymph nodes and would provide additional opportunities for modulating adaptive immune responses via regulation of lymphatic migration of neutrophils.
In conclusion, these data suggest that the rapid dissemination of neutrophils from the site of bacterial inflammation to secondary lymphoid organs may enhance lymphocyte responses, thereby providing an additional link between the innate and adaptive immune systems.
Discussion
In addition to their well-known role in pathogen killing in inflamed tissues, recent evidence indicates that neutrophils may also affect adaptive immune responses in lymphoid organs 2 . We have established a photoconvertible transgenic system to track the fate of neutrophils recruited to sites of inflammation and used this system to create a comprehensive picture of the early events during anti-microbial immune responses. Neutrophils were rapidly recruited in response to both microbial and sterile challenges but after their arrival in inflamed skin, neutrophil phenotypes and fates diverged. Neutrophils responding to microbial lesions expressed higher levels of the activation and migration molecule CD11b, whereas neutrophils recruited to sterile lesions showed augmented expression of CXCR2 and CD62L. In bacterial infections, the signals generated in response to microbial stimuli are superimposed on top of the cell and tissue damage signals produced in sterile inflammation. Therefore, the altered phenotype of neutrophils responding to S. aureus compared with neutrophils in sterile lesions is likely due to a combined effect of tissue injury signals together with specific microbial stimuli that are absent in sterile inflammation.
The differences in molecules that guide neutrophil migration, in combination with the chemoattractant signals selectively generated in bacteria-containing lymph nodes led to distinct migration patterns. Specifically, neutrophils migrated from skin ARTICLE to draining lymph nodes only when bacteria were present at the primary lesion. As the main immune subset to leave the site of primary injury early in the response, neutrophils may be crucial not only for controlling pathogens that escape from skin but also for initial antigen transport from the site of invasion and the initiation of immune responses in draining lymph nodes. Conversely, this pathway may be exploited by pathogens since neutrophils can act as 'Trojan horses' to aid the spread of infection [27] [28] [29] . Modulating neutrophil migration to the lymph nodes may, therefore, present an important avenue for therapeutic intervention in the treatment of inflammation and infection.
A recent study demonstrated a role for S. aureus-produced cytotoxin a-hemolysin in inhibiting neutrophil recruitment to inflamed skin 30 . We observed no significant difference in neutrophil recruitment to the ear in response to killed S. aureus compared with sterile injury suggesting that the level of a-hemolysin in killed S. aureus is not sufficient to inhibit neutrophil recruitment to the site of inflammation. However, it would be intriguing to determine whether a-hemolysin can modulate lymphatic migration of neutrophils between inflamed skin and draining lymph nodes.
With the aid of two-photon microscopy, we visualized neutrophil migration in lymphatic vessels of the skin and confirmed, using photoconversion, that neutrophils utilize lymphatics rather than reverse transmigration into blood vessels to migrate from skin to draining lymph nodes. This is consistent with observations obtained in Mycobacterium bovis BCG 8 and Toxoplasma gondii 9 infections. Furthermore, our photoconvertible system provided us with a unique opportunity to examine the mechanism of neutrophil migration from skin to draining lymph nodes. Interestingly, contrary to what was reported by Beauvillain et al. 25 in Freund adjuvant model, we found both neutrophil egress from the skin and entry into the lymph nodes to be independent of CCR7. This is in contrast with CCR7-guided DC migration from skin to draining lymph nodes 31 suggesting that a distinct mechanism is responsible for neutrophil egress from inflamed skin.
Chemokine receptors CXCR2 and CXCR4 have also been implicated in regulating neutrophil migration. CXCR2 mediates neutrophil migration along the vasculature 32 and into tissues 33 while CXCR4 regulates neutrophil release from the bone marrow 34 and lungs 35 and has also been implicated in immune complex-induced recruitment to lymph nodes 36 . Localized inhibition of these chemokine receptors showed that CXCR4 but not CXCR2 was involved in neutrophil migration from skin to draining lymph nodes. An earlier study demonstrated that CXCR4 engagement also promotes cutaneous DC migration to lymph nodes and that its ligand, CXCL12, is expressed in skin lymphatics 37 . Consistent with a prior report 19 , pertussis toxin did not inhibit neutrophil migration to lymph nodes. This suggests that CXCR4 is acting in a Gai-independent manner as has been previously reported for this receptor 38, 39 .
The mechanism of neutrophil egress from microbial lesions also appeared to involve CD11b since localized blockade of this molecule or complete removal of CD11b (in neutrophils from CD11b-deficient mice) inhibited neutrophil migration from skin to lymph nodes. CD11b is a highly versatile molecule that can mediate a wide range of biological functions 40 . It binds to ICAM-1 to mediate neutrophil migration out of the blood vessels to inflammatory sites 41 , forms part of complement receptor 3 and plays a role in neutrophil activation 40 . Other ligands of CD11b include factor X 42 , fibrinogen 43 as well as junctional adhesion molecule JAM-C, which regulates neutrophil transendothelial migration 6, 44 and is expressed by blood and lymphatic endothelial cells 45 . Since ICAM-1 blockade failed to significantly diminish neutrophil migration from inflamed skin, CD11b may modulate lymphatic migration of neutrophils via its interactions with JAM-C or through its role in neutrophil activation via the complement pathway.
Interestingly, lymphatic migration of neutrophils was not inhibited by topical administration of anti-CD11a or anti-CD62L even though both of these antibodies effectively prevented neutrophil recruitment from blood to sites of microbial inflammation. Thus, lymphatic migration of neutrophils appears to be governed by mechanisms that are distinct from the wellcharacterized molecular processes responsible for neutrophil recruitment to sites of inflammation.
Following their arrival in the lymph node, photoconverted skin-egressing neutrophils disappeared within 36 h while photoconverted neutrophils in the skin persisted for several days. Neutrophil persistence in inflamed skin is consistent with an earlier observation of prolonged neutrophil survival in S. aureusinduced lesions 4 . The disappearance of neutrophils from lymph nodes appears to be due to apoptosis since we observed elevated levels of Annexin V staining in neutrophils located in draining lymph nodes. However, it is unclear what drives neutrophil apoptosis in lymph nodes and not the skin since both neutrophils that contain S. aureus and the ones that do not, show elevated levels of Annexin V staining on draining lymph nodes. Thus additional non-microbial factors present in inflamed skin but not in lymph nodes must contribute to neutrophil survival.
Despite their limited lifespan, rapid re-localization from the site of inflammation to draining lymph nodes gives neutrophils the opportunity to modulate early adaptive responses in lymph nodes before the arrival or activation of other innate immune cells. Consistent with this suggestion, we found that neutrophils enhanced B-and T-cell proliferation at the early time points following S. aureus administration. Furthermore, we demonstrate that T-cell proliferation in draining lymph nodes can be modulated by the specific inhibition of neutrophil migration from inflamed skin. This suggests that adaptive immune responses to microbes can be regulated by controlling neutrophil influx from the site of inflammation. Whether the effect on lymphocyte proliferation is mediated directly by lymph node neutrophils, which upregulate MHC class II and co-stimulatory molecules, shuttle antigen to lymph nodes and produce inflammatory mediators, or indirectly via other immune cells recruited or activated by neutrophils remains to be determined. Interestingly, a recent study has found that neutrophils had a suppressive effect on T-cell responses especially in distal lymph nodes 19 . However, this effect was observed 7 days after challenge coinciding with a second wave of neutrophil migration to the lymph nodes. Given the multitude of ways that neutrophils can affect immune responses, the precise effect of neutrophils on the adaptive immune response is likely to be highly dependent on the timing.
In conclusion, our study reveals the mechanisms of neutrophilmediated communication between the site of initial injury and local lymph nodes where adaptive immune responses are initiated.
Methods
Mice. All mice used in this study were on the C57BL/6 background and were housed in specific-pathogen-free conditions. Both male and female animals of 8-12 weeks were used for these experiments. All animal experiments and procedures were approved by the Garvan Institute of Medical Research/St Vincent's Hospital Animal Ethics Committee. C57BL/6 mice were from Australian BioResources (Moss Vale, NSW). The ROSA-CAG-lox-stop-lox-KikGR knock-in and Kaede mice were a kind gift from Michio Tomura and were backcrossed and maintained on the C57BL/6 background. To generate whole-body Kikume transgenic mice ROSA-CAG-lox-stop-lox-KikGR mice were crossed to Rosa26 Cre (Jackson Laboratories). Albino.B6 or C57BL/6 mice with spontaneous mutations in the tyrosinase gene (B6(Cg)-Tyr c-2J /J) as well as CCR7 À / À and Lysozyme M Cre mice were obtained from Jackson Laboratories. Lysozyme M fluorescent reporter mice were generated by crossing Lysozyme M Cre mice to ROSA mT/mG (Jackson Laboratories) mice. CD11b-deficient mice (B6.129S4-Itgam tm1Myd /J) were a kind gift from Dr Karlheinz Peter and were on the C57BL/6 background.
Neutrophil isolation and bone marrow transfer. Bone marrow was harvested by flushing femurs and tibias of donor mice using 2% BCS þ 1 mM EDTA in RPMI. Erythrocytes were removed by lysing with 10 mM KHCO 3 , 0.1 mM EDTA and 166 mM NH 4 Cl and washing twice with RPMI in 2% BCS þ 1 mM EDTA. The resulting cell suspension was transferred intravenously into recipient mice in a volume of 200-300 ml at a ratio of three donors per one recipient. In some instances, neutrophils were purified from bone marrow using an EasySep Mouse Neutrophil Enrichment Kit from Stem Cell Technologies. To analyse the role of CD11b in neutrophil migration to lymph nodes, 2 Â 10 5 CD45.2 CD11b-deficient and Kaede wild-type neutrophils were transferred into the ears of CD45.1 congenic recipients, which were injected with S. aureus 4 h earlier. Mice were killed after a further 4 h and analysed by flow cytometry.
Quantification of neutrophil migration from skin. Microbial inflammation was induced in the ears by injecting 2 Â 10 7 S. aureus bioparticles (Invitrogen) into the ear pinnae, non-microbial inflammation was induced by carefully scratching the ear skin with a sterile 29-gauge needle. Fluorescent bioparticles were generated by in-house labelling using Pacific Blue, Alexa Fluor 647 or Alexa Fluor 680 monoclonal antibody-labelling kits (Invitrogen).
Photoconversion was performed 4 h following the induction of inflammation. For skin photoconversion, ears were irradiated with violet light from a cold-light source fitted with a conversion filter (Zeiss) to minimize thermal damage and phototoxicity. Maximal increase in red fluorescence was achieved by irradiation for 20 min. Photoconverted Kikume red cells were detected by flow cytometry after a further 4 h.
Blocking neutrophil migration from skin. Microbial inflammation was induced as above, and, 4 h later, ear pinnae of photoconvertible mice were injected using a 29-gauge needle with 5 mg of anti-CD11b, (clone M1/70), 10 mg of CD11a (clone M1/74), 10 mg of CD62L (clone Mel14), 10 mg of ICAM-1 (clone YN1/1.7.4), 10 mg LYVE-1( clone 223322, R&D systems) or 10 mg of isotype control antibodies, IgG2b (clone LTF-2, UCSF monoclonal antibody core) or IgG2a (clone 2A3, BioXcell) or SB225002 (Cayman Chemical) in dimethylsulphoxide diluted to 7 mg in 0.9% NaCl, 0.33% Tween 80 or 60 mg of plerixafor/AMD3100 in phosphatebuffered saline (PBS, Adooq Bioscience) or 500 ng of pertussis toxin (List Biological Laboratories) or PBS control, immediately before photoconversion. Draining and non-draining lymph nodes were collected 4 h after photoconversion, single-cell suspensions were created by mechanical disruption on a 100 mM filter and neutrophils were identified by Ly6G and CXCR2 expression.
Blocking neutrophil recruitment from blood. The C57BL/6 mice were given either 170 mg of CD11a (clone M1/74), 20 mg CD11b (clone M1/70), 150 mg of CD62L (clone Mel14), 200 mg of ICAM-1 (clone YN1/1.7.4) or 200 mg of isotype control antibodies IgG2b (clone LTF-2 UCSF monoclonal antibody core) or IgG2a (clone 2A3), 500 ng of pertussis toxin or PBS control and then immunized with S. aureus and analysed 8 h later as previously described.
Neutrophil regulation of T-cell proliferation. Twenty-four hours before induction of inflammation, mice were injected intraperitoneally with either 50 mg of rat-anti-mouse Ly6G (clone 1A8) or 50 mg of isotype control antibody (clone 2A3, BioXcell). Twenty-four hours later, 2 Â 10 7 S. aureus bioparticles were injected into the ear pinnae, mice were bled to confirm depletion and then injected intraperitoneally with either 50 mg of rat-anti-mouse Ly6G or isotype control antibody. To confirm depletion, blood was lysed and stained with purified Ly6G (clone 1A8), then goat-anti-rat-IgG Alexa-555 (Invitrogen), then CD11b-A647 in 2% normal rat serum. Forty-eight and 60 h later, mice were injected with 100 ml BrdU in PBS (0.8 mg ml À 1 , Sigma-Aldrich) intraperitoneally. Seventy-two hours after S. aureus administration, mice were killed.
To test the role of CD11b-mediated neutrophil migration in T-cell proliferation, neutrophils were purified from the bone marrow of CD11b-deficient or wild-type mice and resuspended in DMEM þ 2% FCS þ 2 mM EDTA at a concentration of 2 Â 10 7 cells ml À 1 . A total 4 Â 10 8 S. aureus bioparticles per ml were added to neutrophils and this mixture was incubated at 37 degrees for 15 min, cells were washed and 5 Â 10 5 CD11b-deficient and wild-type neutrophils were transferred into the ear pinna of C57BL/6 mice that were depleted of neutrophils by a single injection of anti-Ly6G (50 mg) 24 h earlier. Proliferation was measured by BrdU incorporation 72 h later as described. Alternatively, wild-type neutrophils were isolated from bone marrow resuspended at 2 Â 10 7 cells per ml and then incubated with 4 Â 10 8 S. aureus bioparticles per ml at 37 degrees for 15 min, neutrophils were washed and then incubated with 1 mg of anti-CD11b or isotype control for 15 min on ice, 5 Â 10 5 neutrophils were transferred into the ear pinnae of C57BL/6 mice made neutropenic by a single injection of anti-Ly6G (50 mg). Proliferation was measured by BrdU incorporation 72 h later as previously described.
Two-photon intravital microscopy. Two-photon imaging was performed using an upright Zeiss 7MP two-photon microscope (Carl Zeiss) with a W Plan-Apochromat 20 Â /1.0 DIC (ultraviolet) Visible-IR water immersion objective. Four external NDDs were used to detect blue (SP 485), green (BP 500-550), red (BP 565-610) and far red (BP 640-710). High repetition rate femtosecond-pulsed excitation was provided by a Chameleon Vision II Ti:Sa laser (Coherent Scientific) with 690-1,064 nm tuning range. In some experiments, B8 Â 10 6 fluorescent Lysozyme M bone marrow cells were injected intravenously 16h before S. aureus challenge into Albino.B6 recipient mice to generate B95% pure population of fluorescent neutrophils in the ear. In vivo labelling of lymphatic endothelial cells was achieved by injecting 1-5 mg of anti-LYVE-1-Alexa Fluor 647 into the ear 30 min before imaging.
We acquired 3 mm z-steps at 512 Â 512 pixels and resolution 0.83 mm per pixel at a frame rate of 10 fps and dwell time of 1.27 ms per pixel using bidirectional scanning.
Intravital two-photon microscopy was based on a previously described method 23 . Anesthesia was induced with 100 mg kg À 1 ketamine/5 mg kg À 1 xylazine and maintained with 1-2% isoflurane supplemented with 100% oxygen at a flow rate of 500 ml min À 1 via a nose cone. Anaesthetized mice were kept warm using a customized heated SmartStage (Biotherm). The ear was immobilized on a base of thermal conductive T-putty (Thermagon Inc.) using Vetbond tissue adhesive (3 M).
Image processing and data analysis. Raw image files were processed using Imaris (Bitplane) software. A Gaussian filter was applied to reduce background noise. Tracking was performed using Imaris spot detection function to locate the centroid of cells. Motility parameters such as cell displacement (or track length calculated as the total length of displacements within the track) and track speed (calculated by dividing track length by time) were obtained using Imaris Statistics function. All modelling and statistical analysis was performed in GraphPad Prism. Means between two normally distributed groups were compared using a Student's t-test.
Antibodies and flow cytometry. Single-cell suspensions were created by mechanical disruption and passed through a 100 mM filter, erythrocytes were removed by lysing with 10 mM KHCO 3 , 0.1 mM EDTA and 166 mM NH 4 Cl solution. If required, ears and lymph nodes were digested with 5 mg of Collagenase D (Roche) and five units of RQ1 DNase (Promega) in DMEM. Cells (2 Â 10 6 ) were stained with antibodies in 100 ml of 1 Â PBS þ 0.2% BSA and 0.1% NaN 3 þ 2 mM EDTA. Ly6G (clone 1A8), CD3-biotin (clone 145-2C11), CD11b (clone M1/70), CD4 (clone GSK1.5), CD8 (clone YTS169.4) and F4/80 biotin (clone BM8) were obtained from UCSF monoclonal antibody core, labelled in-house with either Pacific Blue or Alexa Fluor 647 using antibody-labelling kits (Invitrogen) and used at 2.5-5 mg ml À 1 . Anti-BrdU-FITC (clone B44, 1.3 mg ml À 1 ) was purchased from Becton Dickinson. Streptavidin PE (1 mg ml À 1 ), CD80-Biotin (clone 16-10A1, 1 mg ml À 1 ), CD86-Biotin (clone GL1,1 mg ml À 1 ), MHC class-II-PE (clone AF6-120.1, 0.4 mg ml À 1 ), AnnexinV-APC (5 ml per sample), Annexin V-PE (5 ml per sample) and CD11c-PE-Cy7 (clone HL3, 0.66 mg ml À 1 ) were purchased from BD Pharmingen. CD11b-BV711 (clone M1/70, 0.4 mg ml À 1 ) was obtained from NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8139 ARTICLE BD Horizon. b 2 -Microglobulin-FITC (clone 9S19.8, 0.02 mg ml À 1 ) was bought from Santa Cruz Biotechnology. CD11b-Pacific Blue (clone M1/70, 0.5 mg ml À 1 ), CD11b-Alexa Fluor 647 (clone M1/70, 0.66 mg ml À 1 ), Fc block (clone 93, 1.3 mg ml À 1 ) and streptavidin PE-Cy7 (0.2 mg ml À 1 ) were purchased from eBioscience. Purified CXCR2 (clone 242216, 2.5 mg ml À 1 R&D systems) was labelled in house. Goat-anti-Rat IgG-Alexa Fluor 555 (4 mg ml À 1 ) was purchased from Invitrogen. Mouse serum for blocking was obtained from C57BL/6 mice or purchased from Jackson ImmunoResearch. CD3 PE-Cy7 (clone 17A2, 1 mg ml À 1 ) was bought from Biolegend. Samples were stained with DAPI (diluted 1/100,000), to exclude dead cells and data were acquired on an LSRII (BD Biosciences). Data were analysed using FlowJo software (Tree Star Inc).
Statistical analysis. The statistical significance of experimental results was determined using either unpaired or paired two-tailed student's t-test for comparisons of two groups. One-way or two-way analysis of variance with Bonferroni correction for comparisons of multiple groups was used to compare three or more groups. All the tests were performed using GraphPadPrism 6.0b (GraphPad Software).
